Regeneron Pharmaceuticals has developed a drug that targets a pathway known as interleukin-6 or IL-6, which can affect inflammation. It's already approved for rheumatoid arthritis and could help very sick Covid-19 patients in respiratory distress.

Regeneron Pharmaceuticals

Tarrytown

Regeneron Pharmaceuticals startup from Tarrytown, United States is ranked null out of 2449 worldwide and null from the 748 startups in United States. See more information and additional rankings on the StartupBlink Global Ecosystem Map